SARATOGA, Calif., Sept. 23, 2020 /PRNewswire/ — CapsoVision, an innovator in the gastroenterology diagnostics market, today announced that the U.S Food & Drug Administration (FDA) will apply enforcement
Today Silicon Valley medical device innovator CapsoVision, Inc. announced a distribution partnership with PENTAX Medical to sell CapsoCam Plus®, the only capsule endoscope that includes four cameras and offers 360° panoramic lateral imaging of the small bowel.
CapsoVision is pleased to announce that it will exhibit their innovative and award-winning CapsoCam Plus® capsule endoscopy system at Digestive Disease Week® (DDW) 2018 at the Walter E. Washington Convention Center in Washington D.C.
Today Silicon Valley-based CapsoVision, Inc. announced CE Mark approval for their innovative CapsoCam Plus® System in patients ages 2 and above.
Today Silicon Valley medical device innovator CapsoVision, Inc. announced the full U.S. launch of CapsoCloud™, a groundbreaking exam management system that allows physicians to extract exam data from the CapsoCam Plus® small bowel capsule endoscope system without the need to process capsules post-ingestion.
Today CapsoVision announced the launch of CapsoView® 3.4, the latest and most innovative software update for the CapsoCam Plus® System, the only capsule endoscopy solution on the market with 360° imaging of the small bowel mucosa.